证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 依依股份(001206) 投资评级 上次评级 [Table_Author] 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮 箱： jiangwenqiang@cindasc.com 相关研究 [Table_OtherReport] 依依股份：业绩增长靓丽，在手订单 饱满，25 年预期乐观 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 [Table_Title] 依依股份：Q1 经营稳健，关税短期扰动，长 期发展无虞 [Table_ReportDate] 2025 年 05 月 05 日 [Table_S 事件：公司发布 ummary] 24&25Q1 业绩。2024 年公司实现收入 17.98 亿元（同比 +34.4%），归母净利润 2.15 亿元（同比+108.3%）；单 24Q4 收入 4.82 亿 元（同比+37.2%），归母净利润 0.64 亿元（同比+304.4% ...

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 华旺科技(605377) | 投资评级 | 无评级 | | --- | --- | | 上次评级 | 无评级 | 姜文镪 新消费行业首席分析师 执业编号：S1500524120004 邮箱：jiangwenqiang@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦 B座 邮编：100031 请阅读最后一页免责声明及信息披露 http://www.cindasc.com 1 [Table_Title] 华旺科技：纸价触底企稳，吨盈利稳步修复， 分红比例大幅提升 [Table_ReportDate] 2025 年 05 月 05 日 [Table_S 事件：公司发布 ummary] 2024 年报&2025 一季报。2024 年公司实现收入 37.68 亿 元（同比-5.2%），归母净利润 4.69 亿元（同比-17.2%），扣非归母净利润 4.34 亿元（同比-17.7%）；单 Q4 收入 9.17 亿元 ...

证券分析师： 李永磊 S0350521080004 [Table_Title] 改性塑料及特种工程塑料表现亮眼， 业绩持续改善 证券分析师： 杨丽蓉 S0350524090008 yanglr@ghzq.com.cn ——金发科技（600143）公司动态研究 2025 年 05 月 05 日 公司研究 评级：买入(维持) 最近一年走势 投资要点： 改性塑料及特种工程塑料表现亮眼，2024 年业绩同比大幅增长 2024 年，公司实现营业收入 605 亿元，同比增长 26%；实现归母净 利润 8.25 亿元，同比增长 160%；经营活动现金流净额为 28.45 亿 元，同比增加 18%。毛利率 11.3%，同比-0.7 个 pct；净利率 0.4%， 同比提升 0.3 个 pct。2024Q4，公司实现营业收入 200.5 亿元，同 比+47%，环比+17%；实现归母净利润为 1.4 亿元，同比-55%，环 比-53%。毛利率为 9.5%，同比提升 1.8 个 pct，环比-1.3 个 pct；净 利率为-0.4%。2024 年公司业绩改善明显，一方面，公司改性塑料、 特种工程塑料业务在汽车、家电、电子电工、消费 ...

安井食品（ [Table_StockNameRptType] 603345） 公司点评 稳中求进，静待新品发力 ——安井食品 24 年报&25Q1 点评 [Table_Rank] 投资评级：买入（维持） 报告日期： 2025-05-05 | [Table_BaseData] 收盘价（元） | 76.30 | | --- | --- | | 近 个月最高 / 最 低 12 | 107.89/66.13 | | （元） | | | 总股本（百万股） | 293 | | 流通股本（百万股） | 293 | | 流通股比例（%） | 100.00 | | 总市值（亿元） | 224 | | 流通市值（亿元） | 224 | [公司价格与沪深 Table_Chart] 300 走势比较 -38% -22% -6% 10% 26% 5/24 8/24 11/24 2/25 安井食品 沪深300 [Table_Author] 分析师：邓欣 执业证书号：S0010524010001 邮箱：dengxin@hazq.com 联系人：郑少轩 执业证书号：S0010124040001 邮箱：zhengshaoxuan@hazq.c ...

证券研究报告 公司研究 [Table_ReportType] 公司点评报告 [Table_StockAndRank] 可孚医疗(301087) | 投资评级 | 买入 | | --- | --- | | 上次评级 | 买入 | | 执业编号：S1500523080002 | | | --- | --- | | [Table_Author] 唐爱金 邮 | 医药行业首席分析师 箱：tangaijin@cindasc.com | 曹佳琳 医药行业分析师 执业编号：S1500523080011 邮 箱：caojialin@cindasc.com 相关研究 [Table_OtherReport] 销售毛利率逐季提升，长期成长可期 核心品类同比增 30%+, 盈利能力提升 可期 五大产品线均衡发展, 听力保健成长 可期 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦B 座 邮编：100031 [Table_Title] 聚焦核心品类，结构调整提升盈利能力 [Table_ReportDate] 2025 年 05 月 05 日 [Table_S 事件：公 ...

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6]. Core Views - The company reported a strong Q1 2025 performance with revenue of 770 million, a 38% year-on-year increase, and a net profit attributable to the parent company of 190 million, up 60% year-on-year [1][2]. - The growth is attributed to multiple factors including a focus on high-quality brand positioning, innovation-driven product differentiation, and an optimized customer structure [2][3]. - The company has successfully expanded its collaboration with major U.S. furniture retailers, resulting in a diversified and robust customer base [3]. - The production capacity in Vietnam is being efficiently utilized, enhancing order delivery capabilities and solidifying the company's competitive advantage in the global supply chain [3]. - Following the introduction of a 10% temporary tariff, the company has engaged in discussions with clients regarding cost-sharing, with most core retailers showing a cooperative spirit [4]. - The company has adjusted its profit forecasts, expecting net profits for 2025-2027 to be 910 million, 1.11 billion, and 1.38 billion respectively, with corresponding EPS of 5.4, 6.6, and 8.3 [4]. Financial Data Summary - For 2023, the company expects revenue of 1.92 billion, with a growth rate of 31.37%, and a net profit of 407.39 million, reflecting a growth rate of 21.93% [10]. - The projected revenue for 2025 is 3.35 billion, with a net profit of 906.11 million, indicating a growth rate of 32.68% [10]. - The company maintains a low debt-to-asset ratio of 17.84% and a strong return on equity (ROE) projected at 21.16% for 2025 [6][12].

Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company is experiencing pressure on its performance in Q1 2025, with expectations for industry recovery [1] - The company's revenue for 2024 was 4,643 million yuan, a year-on-year decrease of 20.9%, and the net profit attributable to shareholders was 779 million yuan, down 45.9% year-on-year [5][6] - The report indicates that the company's agricultural pesticide revenue for 2024 was 2,906 million yuan, down 17% year-on-year, with a gross margin of 31.20% [6] - The report anticipates a gradual recovery in demand and pricing for certain products in Q1 2025, although some products continue to face pricing pressure [6] Financial Data and Profit Forecast - Total revenue forecast for 2025 is 4,878 million yuan, with a projected year-on-year growth of 5.1% [5] - The net profit attributable to shareholders for 2025 is estimated at 740 million yuan, reflecting a decrease of 5.0% year-on-year [5] - The report projects earnings per share of 0.81 yuan for 2025, with a price-to-earnings ratio of 13 [5] - The gross margin is expected to be 28.4% in 2025, slightly down from previous years [5] - The report includes a detailed breakdown of revenue and gross margin forecasts for the agricultural and fine chemical segments from 2025 to 2027 [6]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a slight pressure in Q1 2025 due to external environmental disturbances, but there is an expectation for gradual improvement in subsequent quarters driven by IP introduction and product changes [6] - The company aims to enhance its online presence and strengthen its offline channels while actively promoting its own brand internationally [6] - The financial outlook remains positive with projected revenue growth and profitability improvements in the coming years [6] Financial Data and Earnings Forecast - Total revenue for Q1 2025 was 5,245 million yuan, a year-on-year decrease of 4.4% [5] - Net profit attributable to the parent company for Q1 2025 was 318 million yuan, down 16.2% year-on-year [5] - The company expects total revenue to reach 27,525 million yuan in 2025, with a projected growth rate of 13.6% [5] - The forecasted net profit for 2025 is 1,604 million yuan, reflecting a year-on-year increase of 14.9% [5] - The gross margin for Q1 2025 was 20.7%, showing a slight increase of 0.49 percentage points year-on-year [6] Business Performance - The traditional core online business continued to show high growth, while the offline channels are being enhanced through focused strategies [6] - The company is actively expanding its retail presence, with revenue from large retail stores reaching 4.01 billion yuan in Q1 2025, an increase of 8% year-on-year [6] - The company is also focusing on product diversification and enhancing product appeal through collaborations with various IPs [6] Strategic Initiatives - The company is pursuing a dual strategy of enhancing its traditional core business while exploring new product categories and international markets [6] - The ongoing development of the "Nine Wood" retail brand is expected to attract younger consumers and increase market share [6] - The company plans to maintain a high dividend payout ratio, with a cash dividend of 66% and a combined dividend and buyback ratio of 73% for 2024 [6]

纺织服饰 2025 年 05 月 05 日 比音勒芬 (002832) ——主品牌持续领跑行业，积极投入培育第二成长曲线 报告原因：有业绩公布需要点评 买入（维持） | 市场数据： | 2025 年 04 月 30 日 | | --- | --- | | 收盘价（元） | 16.48 | | 一年内最高/最低（元） | 32.38/16.10 | | 市净率 | 1.7 | | 股息率%（分红/股价） | 6.07 | | 流通 A 股市值（百万元） | 6,418 | | 上证指数/深证成指 | 3,279.03/9,899.82 | | 注："股息率"以最近一年已公布分红计算 | | 04-30 05-31 06-30 07-31 08-31 09-30 10-31 11-30 12-31 01-31 02-28 03-31 04-30 -60% -40% -20% 0% 20% 40% 比音勒芬 沪深300指数 (收益率) 相关研究 上 市 公 司 《比音勒芬（002832）点评：业绩表现显 著优于行业，新品牌投入培育第二成长曲 线》 2024/10/31 《比音勒芬（002832）点评：24Q2 扣非 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [7]. Core Views - The company reported a revenue of 79.118 billion yuan in Q1 2025, representing a year-on-year growth of 10.06%. The net profit attributable to the parent company was 5.487 billion yuan, up 15.09% year-on-year, while the net profit excluding non-recurring items was 5.364 billion yuan, reflecting a growth of 15.61% year-on-year [2][5]. Summary by Sections Revenue Growth - The company's revenue growth is driven by both domestic and overseas sales, with a 10.06% year-on-year increase in Q1 2025. Domestic market revenue grew by 7.8%, supported by investments in original technology and a strengthened product lineup. The Casarte brand saw revenue growth exceeding 20%. The overseas market revenue increased by 12.6%, with significant growth in North America and emerging markets [10]. Profitability Improvement - The gross margin improved by 0.06 percentage points year-on-year, with both domestic and overseas business margins increasing. The operating profit grew by 12.76% year-on-year due to a reduction in sales and management expense ratios, alongside a slight increase in R&D expense ratio [10]. Employee Stock Ownership Plan - The company announced an employee stock ownership plan for both A-shares and H-shares, with a total investment of 757 million yuan for A-shares and 63 million yuan for H-shares. The performance targets for the plan are set at a return on equity (ROE) exceeding 17.7% for 2025 and 2026 [10]. Financial Forecast - The company is expected to achieve net profits of 21.44 billion yuan, 24.285 billion yuan, and 26.756 billion yuan for the years 2025, 2026, and 2027, respectively. The corresponding price-to-earnings (PE) ratios are projected to be 10.96, 9.67, and 8.78 [10].